Health CareMedical Equipment and Services
  • Price (USD)19.83
  • Today's Change-0.49 / -2.41%
  • Shares traded4.74m
  • 1 Year change-39.04%
  • Beta1.3285
Data delayed at least 15 minutes, as of Jun 08 2023 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

  • Revenue in USD (TTM)7.34bn
  • Net income in USD609.50m
  • Incorporated2016
  • Employees14.50k
  • Location
    Avantor IncBuilding One100 W Matsonford Rd Ste 200RADNOR 19087United StatesUSA
  • Phone+1 (610) 386-1700
  • Fax+1 (302) 636-5454
  • Websitehttps://www.avantorsciences.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Itron Inc1.81bn-22.47m3.30bn5.48k--2.8278.751.82-0.4992-0.499240.1425.800.7465.835.96331,358.60-0.924-1.50-1.19-1.9729.9429.37-1.24-1.741.1915.450.2751---9.39-2.3188.02---16.79--
Integra Lifesciences Holdings Corp1.56bn171.88m3.35bn3.72k19.832.0011.502.152.072.0718.7920.450.42131.716.12419,633.004.643.425.043.7962.9063.7711.007.972.408.210.46220.000.98665.566.7910.791.60--
Badger Meter Inc592.27m71.55m4.43bn1.98k62.049.6745.197.482.432.4320.1515.621.003.067.29299,730.3012.1310.8814.6812.9439.1839.0512.0810.691.97--0.0040.6611.957.049.2213.46-17.1311.65
Vontier Corp3.21bn233.90m4.82bn8.10k20.887.5713.571.501.481.4820.294.090.7495.237.10396,629.605.45--6.84--45.0143.897.2813.831.122.290.79811.446.484.97-2.831.43-2.59--
MKS Instruments Inc3.60bn148.00m6.76bn10.90k38.851.5215.261.882.612.6157.4966.730.44952.426.54330,183.501.858.252.019.1143.0145.204.1113.801.932.060.525312.9920.2513.11-39.61-0.609239.284.53
Cognex Corporation924.81m173.81m9.58bn2.44k55.666.6249.5310.360.99710.99715.318.380.47331.996.10378,864.008.8912.859.9313.9671.5973.4718.7925.212.78--0.0049.44-2.995.60-22.99-5.80-7.329.61
Bio Rad Laboratories Inc2.78bn-188.96m10.70bn8.20k--1.09--3.85-6.25-6.2593.45329.760.19821.845.78338,906.20-1.3512.23-1.4113.0154.9755.62-6.8050.634.280.66050.10930.00-4.125.34-185.27--0.2591--
Bruker Corporation2.62bn311.50m10.87bn8.53k35.269.2126.874.152.102.1017.658.040.71671.585.92307,448.708.537.7811.7010.5751.8949.0811.9110.261.2219.040.503811.614.677.467.0414.9924.214.56
Avantor Inc7.34bn609.50m13.39bn14.50k22.082.6813.371.820.89810.898110.827.400.53925.345.60506,365.504.542.455.122.7634.5632.918.414.091.033.850.54820.001.7143.2030.37--39.56--
Revvity Inc2.73bn360.52m13.98bn16.70k39.091.7518.005.132.857.6021.5663.770.1851.933.57163,308.102.455.702.706.5062.0455.9013.2215.652.156.270.35186.23-13.487.97-42.3614.2416.980.00
Waters Corporation2.97bn688.85m14.76bn8.20k21.7424.5918.044.9711.5011.5049.5010.160.93452.834.60361,714.4021.7018.8028.3623.3657.9658.3523.2223.991.5921.730.71160.006.685.182.154.4115.19--
Fortive Corp5.91bn763.70m24.18bn18.00k32.052.4519.754.092.132.1316.5227.920.36864.436.32328,327.804.764.685.685.7857.8656.6812.9214.790.71679.410.238614.3710.870.240730.27-1.50-2.920.00
Data as of Jun 08 2023. Currency figures normalised to Avantor Inc's reporting currency: US Dollar USD

Institutional shareholders

42.95%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Investment Management, Inc.as of 31 Mar 202376.07m11.28%
The Vanguard Group, Inc.as of 31 Mar 202361.26m9.08%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 202330.07m4.46%
BlackRock Fund Advisorsas of 31 Mar 202324.66m3.66%
Canada Pension Plan Investment Boardas of 31 Mar 202324.37m3.61%
Boston Partners Global Investors, Inc.as of 31 Mar 202316.39m2.43%
Barrow, Hanley, Mewhinney & Strauss LLCas of 31 Mar 202316.19m2.40%
American Century Investment Management, Inc.as of 31 Mar 202315.11m2.24%
Janus Henderson Investors US LLCas of 31 Mar 202312.94m1.92%
Wellington Management Co. LLPas of 31 Mar 202312.65m1.88%
More ▼
Data from 31 Mar 2023 - 31 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.